Optimizing Ophthalmic Drug Delivery for Therapeutic Effectiveness
In this ONdrugDelivery article, Barbara Morgan, Ph.D., General Manager of CDMO Services at Lubrizol Life Science Health, offers a fresh take on one of today’s most challenging ophthalmic drug delivery issues as well as trends in the industry. She discusses how eye physiology impacts product formulation and choice of dosage form, and how advanced delivery technologies are providing new options for formulators seeking to improve the bioavailability or stability of their ophthalmic treatments.
In this article, Dr. Morgan discusses:
- Trending Towards Complexity
- Increase in Drug Approvals
- Topicals for the Front of the Eye
- Posterior Ocular Drug Delivery
- Ophthalmic Injectables
- Liposomes and Particulates
- Micro and Nano Particulates
- Ocular Implants